114 related articles for article (PubMed ID: 15359854)
1. [Complications in interferon therapy for chronic hepatitis C].
Arase Y
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):519-22. PubMed ID: 15359854
[No Abstract] [Full Text] [Related]
2. [Side effects of interferon therapy for chronic hepatitis C].
Arase Y
Nihon Rinsho; 2006 Jul; 64(7):1363-7. PubMed ID: 16838657
[TBL] [Abstract][Full Text] [Related]
3. [Ocular findings in hepatitis C patients treated with interferon].
Mrugacz M; Lebensztejn D
Klin Oczna; 2010; 112(7-9):253-6. PubMed ID: 21121130
[TBL] [Abstract][Full Text] [Related]
4. [The neuropsychiatric side effects of the interferon therapy in patients with chronic hepatitis B and C].
Lapiński TW; Prokopowicz D
Pol Merkur Lekarski; 1999 Jul; 7(37):8-11. PubMed ID: 10522402
[TBL] [Abstract][Full Text] [Related]
5. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
Sidhu-Malik NK; Kaplan AL
J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of adverse effects in ribavirin and interferon combination therapy].
Izumi N
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):523-7. PubMed ID: 15359855
[No Abstract] [Full Text] [Related]
7. [Treatment of extrahepatic manifestations associated with hepatitis C virus infection].
Cacoub P
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B210-9. PubMed ID: 12180291
[No Abstract] [Full Text] [Related]
8. [Treatment of chronic hepatitis C: side effects, tolerability and quality of life].
Gournay J; Richou C
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B60-75. PubMed ID: 12180310
[No Abstract] [Full Text] [Related]
9. [A case report of interferon-associated retinopathy].
Sobolewski P; Lapiński T
Klin Oczna; 1999; 101(3):213-6. PubMed ID: 10526448
[TBL] [Abstract][Full Text] [Related]
10. [Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon].
Sarrecchia C; Niutta P; Testore GP; Sordillo P; Proietti F; Andreoni M
Recenti Prog Med; 2001 May; 92(5):336-9. PubMed ID: 11413892
[TBL] [Abstract][Full Text] [Related]
11. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
[TBL] [Abstract][Full Text] [Related]
12. Interferon induced glomerular disease in a patient with chronic hepatitis C.
Suresh RL; Suryati Y; Merican I
Med J Malaysia; 2003 Oct; 58(4):594-6. PubMed ID: 15190636
[TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis C, depression and interferon.
Horsmans Y
J Hepatol; 2005 Jun; 42(6):788-9. PubMed ID: 15885347
[No Abstract] [Full Text] [Related]
14. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
15. [Quality of life of patients with chronic hepatitis C: effect of treatments].
Couzigou P
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B257-63. PubMed ID: 12180299
[No Abstract] [Full Text] [Related]
16. Diffuse cutaneous eruption due to interferon alfa and ribavirin treatment of chronic hepatitis C.
Savk E; Uslu G; Karaoğlu AO; Sendur N; Karaman G
J Eur Acad Dermatol Venereol; 2005 May; 19(3):396-8. PubMed ID: 15857485
[No Abstract] [Full Text] [Related]
17. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
Berk DR; Mallory SB; Keeffe EB; Ahmed A
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):142-51. PubMed ID: 16919505
[TBL] [Abstract][Full Text] [Related]
18. Prediction models for feverishness developed during interferon therapy of chronic hepatitis C patients.
Uesawa Y; Motege E; Dai Y; Ishii K; Mohri K
Pharmazie; 2010 Feb; 65(2):114-6. PubMed ID: 20225655
[TBL] [Abstract][Full Text] [Related]
19. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
[No Abstract] [Full Text] [Related]
20. Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature.
Midturi J; Sierra-Hoffman M; Hurley D; Winn R; Beissner R; Carpenter J
Clin Infect Dis; 2004 Dec; 39(11):1724-9. PubMed ID: 15578378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
